The government of Rwanda is planning to engage private sector in a bid to improve healthcare across the country.
Rwanda is looking for investors that will inject cash into its plans to set up a pharmaceutical plant. The move according to Rwanda Development Board (RDB), Rwanda’s agency charged with Fast tracking economic development, was in in a bid to cut cost the country incur in the importation of medicament.
Mr Francis Gatare RDB’s chief executive, announced that the government was looking for investors willing to pump in cash in the plant that is set t0 manufacture drugs, medical consumables, devices and equipment and laboratory supplies.
The US$9.9 million project is set to cut Rwanda’s expenditure on the importation of drugs by US$50 million when complete. “The government has been making efforts to leverage investors to make sure we can have pharmaceutical products manufactured in the country at an affordable cost,” said Mr Gatare on the sidelines of the ongoing Global African Investment Summit in Kigali, Rwanda.
In order to address human capital challenges that may arise from the project, the government will be banking on the Biomedical Center of Excellence hosted at the Kigali innovation City to offer the required human capital.
Rwanda currently imports over 95 per cent of pharmaceuticals which include oral solids, suspensions, suppositories and infusions. The market size for pharmaceutical drugs according to RDB, is mainly influenced by the existence of national health insurance system.